develop
innov
medicin
person
biomed
approach
call
new
gener
easili
tunabl
biomateri
manufactur
appli
straightforward
lowpric
technolog
product
function
bacteri
polyhydroxyalkano
pha
nanobead
har
natur
carbonstorag
granul
product
system
thrill
recent
develop
branch
nanobiotechnolog
employ
protein
intrins
bind
pha
granul
tag
immobil
recombin
protein
interest
design
function
nanocarri
wide
rang
applic
addit
implement
new
methodolog
platform
regard
product
endotoxin
free
pha
nanobead
use
gramposit
bacteria
open
new
avenu
biomed
applic
prompt
seriou
consider
possibl
exploit
bacteri
cell
factori
altern
tradit
chemic
synthesi
sourc
novel
bioproduct
could
dramat
expand
possibl
applic
biopolym
clinic
editor
centuri
come
age
person
medicin
grow
use
biomateri
clinic
set
review
articl
author
describ
use
natur
polyhydroxyalkano
pha
nanoparticul
form
within
bacteri
cell
easili
function
potenti
use
would
includ
highaffin
biosepar
enzym
immobil
protein
deliveri
diagnost
etc
challeng
approach
remain
possibl
toxic
endotoxin
high
cost
product
healthfocus
nanotechnolog
put
screen
grow
spectrum
materi
whose
properti
modifi
fabric
merg
synthesi
smart
function
natur
polym
allow
straightforward
costeffect
product
novel
materi
specif
design
target
applic
perform
polym
synthet
origin
investig
nanotechnolog
applic
well
howev
case
product
function
usual
two
separ
process
among
natur
polym
polyhydroxyalkano
pha
highli
tunabl
bacteri
polyest
play
import
role
develop
next
gener
biomateri
figur
properti
greatli
influenc
type
eg
short
chain
length
pha
sclpha
medium
chain
length
pha
mclpha
homogen
hydroxyalkano
monom
build
block
other
figur
abil
edit
redirect
bacteri
cell
system
metabol
genet
engin
enabl
construct
platform
produc
versatil
materi
carri
wide
rang
function
group
confer
desir
properti
polym
altern
direct
use
highli
structur
natur
pha
nanoparticul
entiti
form
within
bacteri
cell
open
new
avenu
attract
biomateri
design
tailormad
bead
function
use
intrins
bacteri
granul
produc
system
possibl
phospholipidco
inclus
carri
granuleassoci
protein
gap
surfac
pha
synthas
involv
polymer
biopolyest
ii
pha
depolymeras
respons
pha
mobil
iii
phasin
main
structur
compon
gap
iv
protein
enzym
relat
synthesi
pha
monom
well
transcript
regul
classifi
gap
figur
implement
new
asset
asid
broaden
potenti
allow
custom
fine
tune
improv
polym
perform
specif
applic
figur
nanostructur
materi
produc
bacteria
becom
increasingli
recogn
function
bead
great
biotechnolog
biomed
potenti
function
complex
architectur
pha
inclus
base
interact
protein
embeddedattach
pha
core
exploit
toolbox
display
molecul
carri
specif
function
figur
wide
scope
applic
perform
engin
pha
bead
demonstr
highaffin
biosepar
enzym
immobil
protein
deliveri
natur
environ
diagnost
antigen
deliveri
system
mani
other
tabl
herein
revis
divers
cell
system
avail
produc
function
pha
nanobead
underlin
specif
properti
context
suitabl
differ
applic
highlight
advantag
differ
granuleassoci
protein
gap
address
possibl
gap
need
fulfil
importantli
power
combin
synthet
biolog
microengin
creat
appropri
framework
futur
applic
pha
nanobead
final
compar
properti
nanoparticl
base
bacteri
select
synthet
polyest
despit
fact
natur
occur
nanoparticl
present
million
year
nanotechnolog
first
schemat
represent
current
use
strategi
pha
function
center
around
addedvalu
pha
product
vivo
pha
modif
base
peptid
function
pha
nanobead
use
gap
recombin
protein
anchor
pha
granul
nonspecif
bind
vivo
chemic
modif
incorpor
function
group
side
chain
polym
appli
metabol
engin
system
biolog
approach
similarli
vivo
vitro
approach
peptid
function
base
use
gap
nonspecif
bind
underli
principl
vitro
chemic
modif
might
base
polym
synthesi
modif
foremost
focus
vitro
manmad
particl
nevertheless
depend
target
applic
vivo
biolog
vitro
synthet
approach
fusion
protein
immobil
pha
granul
surfac
might
better
meet
requir
tabl
vivo
pha
granul
function
consist
gap
fusion
immobil
onto
granul
surfac
simultan
granul
format
insid
phaproduc
host
figur
hand
product
bioinspir
construct
vitro
base
pha
extract
follow
vitro
bead
product
vitro
gap
fusion
protein
immobil
via
gapbead
interact
figur
main
advantag
vitro
cellfre
system
possibl
tight
control
nanoparticl
disassembl
reassembl
process
ii
absenc
competit
among
recombin
gapfus
wild
type
protein
iii
tight
control
particl
size
immobil
proteinact
agent
concentr
iv
possibl
endotoxin
remov
crucial
design
everi
biomed
setup
nevertheless
pha
isol
vitro
nanobead
product
requir
tediou
methodolog
eg
avoid
pha
particl
aggreg
comparison
isol
vivo
produc
pha
granul
also
use
nonenvironment
friendli
solvent
need
vitro
technolog
mention
significantli
increas
cost
vitro
pha
nanobead
product
make
technolog
suitabl
mainli
addedvalu
applic
tight
control
particl
size
activ
agent
concentr
need
line
safeti
vitro
approach
highli
conveni
nanomed
purpos
includ
nanofabr
imag
drug
deliveri
tissu
engin
use
endotoxinfre
pha
requisit
importantli
fabric
endotoxinfre
pha
vehicl
also
achiev
use
vivo
set
see
applic
protein
deliveri
natur
environ
necessari
acquir
endotoxin
free
pha
benefit
vivo
approach
bacteri
natur
produc
nanoscal
particul
entiti
use
straightforward
manner
furthermor
bacteri
polymer
particl
function
vivo
isol
clear
environment
econom
advantag
produc
chemic
particl
function
achiev
recombin
express
fusion
protein
natur
gap
use
anchor
tag
foreign
protein
immobil
perfect
exampl
biof
tag
pseudomona
putida
base
use
intrins
p
putida
pha
granul
scaffold
immobil
fusion
protein
vivo
ferment
optim
pha
product
condit
accomplish
granul
decor
biofprotein
fusion
obtain
end
product
figur
depend
protein
releas
treatment
fusion
protein
recov
good
puriti
sinc
phasin
repres
major
gap
addit
possibl
minim
presenc
gap
protein
increas
yield
fusion
protein
bind
puriti
investig
biof
system
proven
effici
vivo
coat
mclpha
granul
deriv
insectspecif
toxin
protein
gener
bioplasticbiofinsect
specif
toxin
complex
indic
excel
perform
biof
tag
devic
spread
activ
polypeptid
environ
without
need
activ
agent
releas
purif
similarli
organophosphohydrolas
agrobacterium
radiobact
immobil
polyest
inclus
recombin
escherichia
coli
shown
suitabl
bioremedi
applic
test
new
vivo
asset
analyz
limit
indic
possibl
room
improv
current
trend
deal
implement
new
methodolog
platform
synthet
biolog
improv
product
process
product
highlight
import
reprogram
approach
optim
system
design
strategi
focus
meet
necess
specif
applic
line
fine
tune
biolog
interfac
use
pha
vehicl
address
key
factor
pha
machineri
permit
overcom
biolog
barrier
reach
maxim
vivo
coat
pha
nanobead
time
avoid
side
effect
concern
disord
granul
biodistribut
cell
divis
see
differ
gapsdiffer
advantag
hydrophob
vs
coval
bind
divers
gap
offer
gentl
altern
flexibl
highli
tunabl
design
specif
tag
suitabl
person
requir
differ
applic
thu
window
possibl
specif
gap
offer
impli
differ
mode
connect
recombin
protein
pha
tabl
comparison
pha
nanoparticl
vitro
vivo
product
process
applic
cost
vitro
ref
product
bacteria
synthet
product
use
renew
sourc
product
harsh
chemic
need
polym
isol
particl
product
simultan
product
function
function
posterior
nanobead
product
nanobead
assembl
disassembl
tightli
control
tight
control
bead
assembl
disassembl
competit
recombin
wild
type
gap
function
target
protein
gap
particl
size
control
biotechnolog
product
process
tight
control
particl
size
immobil
protein
concentr
variat
might
repres
challeng
tight
control
immobil
protein
concentr
product
cost
total
product
cost
includ
vivo
particl
product
cost
particl
purif
lower
product
cost
compar
vitro
produc
particl
sinc
addit
function
need
higher
product
cost
compar
vivo
produc
particl
total
price
account
polym
synthesi
isol
endotoxin
remov
vitro
particl
synthesi
function
nanobead
coval
hydrophob
nonspecif
figur
although
far
littl
known
structur
interact
pha
granul
phasin
highli
attract
among
gap
larg
due
wide
assort
structur
differ
composit
compar
gap
figur
phasin
util
affin
tag
protein
engin
design
build
recombin
protein
purif
system
provid
low
cost
method
product
purif
high
ad
valu
protein
continu
way
signific
improv
biosepar
technolog
made
upgrad
system
interconnect
phasin
target
protein
via
selfcleav
intein
approach
enabl
vivo
recombin
protein
immobil
onto
granul
releas
purifi
protein
nativ
sclpha
particl
recov
turn
push
biosepar
technolog
sever
step
ahead
toward
conveni
econom
product
vivo
immobil
correctli
fold
eukaryot
protein
surfac
pha
granul
across
phasin
protein
use
fluoresc
activ
cell
sort
fac
base
diagnost
complet
differ
context
vivo
tag
bind
vitro
synthes
pha
nanoparticl
vitro
hydrophob
bind
phap
fusion
protein
protein
ligand
eg
mannosyl
human
glycoprotein
hagp
human
epiderm
growth
factor
hegf
report
anoth
outstand
applic
phasin
receptormedi
drug
deliveri
mostli
util
phasin
phap
ralstonia
eutropha
bind
sclpha
exclus
exampl
mclpha
bind
p
putida
phaf
phasin
environment
applic
biof
system
identifi
phasin
phap
protein
aeromona
hydrophila
phap
haloferax
mediterranei
paracoccu
denitrifican
bacillu
megaterium
other
revis
deepli
studi
nanobiotechnolog
purpos
likewis
appli
vitro
approach
substrat
bind
domain
pha
depolymeras
use
hydrophob
anchor
fusion
protein
pha
nano
microbead
differ
strategi
vivo
immobil
recombin
protein
onto
pha
nanobead
surfac
relay
advantag
coval
gappha
bind
use
p
aeruginosa
p
putida
r
eutropha
b
megaterium
pha
synthas
tag
phasinpha
interact
usual
result
slow
nontrigg
protein
releas
time
physiolog
condit
moreov
specif
environment
condit
alter
releas
rate
contrast
coval
attach
enabl
uniqu
natur
crosslink
protein
polymer
support
allow
better
control
protein
releas
kinet
pha
synthas
offer
possibl
coval
proteinpha
conjug
nand
ctermin
pha
synthas
shown
suitabl
vivo
assembl
function
polyest
bead
approach
base
pha
nanobead
function
phac
help
circumv
wash
noncoval
bound
fusion
protein
process
particl
intrins
label
tailor
coval
display
protein
applic
antibodi
capturebas
diagnost
eg
immunochromatograph
strip
bachandelut
biosepar
applic
modular
arrang
protein
domain
provid
larg
figur
vivo
immobil
fusion
protein
bioplast
biof
tag
procedur
consist
ferment
p
putida
optim
pha
product
condit
isol
granul
carri
biofprotein
fusion
crude
cell
lysat
simpl
centrifug
step
releas
fusion
protein
via
deterg
treatment
modifi
design
space
product
custommad
materi
introduc
enterokinas
digest
site
tag
target
protein
latter
effici
releas
polym
support
provid
effici
costeffect
methodolog
obtain
ad
valu
product
similarli
facilit
target
protein
releas
biobead
thrombin
cleavag
site
use
linker
well
previous
mention
autolyt
intein
enabl
straightforward
liber
target
protein
addit
protein
unspecif
absorb
pha
altern
rout
intracellularlli
produc
enzym
decor
pha
bead
consist
simultan
synthesi
insolubl
protein
inclus
bodi
pha
granul
charg
particl
creat
introduc
acid
coil
via
ntermin
phac
structur
use
captur
enzym
interest
coexpress
host
cell
contain
basic
coil
fuse
cterm
coil
held
togeth
hydrophob
electrostat
interact
therefor
follow
understand
proteinpha
interact
biophys
point
view
undoubtedli
widen
biotechnolog
clinic
potenti
bioplast
fact
case
indic
phasinpha
interact
influenc
natur
two
compon
also
presenc
gap
interfer
play
role
mediat
element
facilit
bind
instanc
optim
biof
system
minim
dosag
natur
phasin
p
putida
illustr
import
understand
molecular
basi
underli
phaphasin
interact
biolog
consequ
also
mechanist
studi
pha
granul
produc
machineri
function
dynam
factor
direct
gappha
bind
togeth
assist
overcom
technic
hurdl
indic
bottleneck
import
design
bioinspir
nanoparticl
see
edit
streamlin
refactor
wild
type
strain
enhanc
protein
immobil
section
detail
bug
system
scale
wild
type
recombin
cell
success
produc
pha
natur
recombinantli
broad
rang
bacteria
show
mani
microorgan
desir
properti
could
perform
function
cell
factori
product
function
pha
bead
e
coli
default
host
microorgan
recombin
protein
product
often
first
choic
fact
strain
serv
workhors
basic
appli
research
worldwid
larg
due
possibl
high
recombin
protein
yield
achiev
remark
e
coli
previou
nonpha
produc
pathway
engin
set
produc
gl
cell
dri
weight
cdw
final
pha
content
use
coproduc
sever
tag
protein
maltos
bind
protein
mbp
lacz
chloramphenicol
acetyltransferas
cat
polyhydroxybuyr
phb
granul
e
coli
cell
protein
purifi
yield
mgg
cdw
current
appli
recombin
e
coli
cell
allow
cover
granul
surfac
total
protein
associ
bead
use
wild
type
p
putida
strain
much
achiev
note
differ
bacteri
strain
differ
pha
produc
capac
regard
polyest
type
sclor
mclpha
rel
amount
cdw
besid
caus
alter
final
recombin
protein
yield
might
consequ
type
gap
use
immobil
recombin
protein
affect
specif
recombin
proteinpha
interact
importantli
r
eutropha
natur
produc
gl
phb
get
cdw
similarli
recombin
product
e
coli
yield
mclpha
obtain
p
putida
reach
p
putida
product
upgrad
intracellular
mclpha
incorpor
knockout
mutat
betaoxid
gene
fada
fadb
recombin
e
coli
abl
produc
mclpha
betaoxid
impair
due
delet
fadb
wherea
qi
et
al
use
metabol
rout
strategi
inhibit
fatti
acid
betaoxid
acryl
acid
recombin
e
coli
fadr
produc
mclpha
addit
phaj
encod
r
specif
enoylcoa
hydratas
demonstr
suppli
pha
biosynthesi
via
betaoxid
pathway
coexpress
phac
e
coli
led
product
pha
monom
composit
contain
unrel
carbon
sourc
though
e
coli
remain
commerci
valuabl
host
phb
largescal
product
polym
degrad
avoid
side
endotoxin
contamin
previous
mention
rel
low
yield
mclpha
substanti
limit
use
biomed
purpos
also
overexpress
foreign
gene
physiolog
rate
usual
trigger
spectrum
conform
stress
respons
caus
accumul
insolubl
protein
version
reach
nativ
conform
pseudospher
protein
aggreg
inclus
bodi
consid
undesir
byproduct
protein
product
process
bottleneck
loss
plasmid
due
instabl
introduc
gene
use
antibiot
gene
express
expens
induc
partial
solv
howev
still
repres
challeng
review
take
togeth
advantag
use
wild
type
strain
host
overlook
specif
strategi
appli
compon
pha
machineri
drive
product
high
content
pha
immobil
recombin
protein
wild
type
strain
report
e
coli
posit
side
great
understand
pha
synthesi
model
mclpha
produc
strain
p
putida
gain
system
biolog
omic
data
genomescal
metabol
model
etc
power
genet
tool
base
synthet
biolog
support
bottomup
approach
might
use
design
p
putida
strain
gener
addedvalu
bioproduct
activ
mclpha
base
nanobead
great
valu
bacterium
autolyt
special
strain
mclpha
product
also
demonstr
due
broad
metabol
versatil
genet
plastic
allow
varieti
renew
carbon
sourc
use
pha
product
p
putida
one
promin
candid
protein
product
asid
pseudomona
mani
gramposit
gramneg
eubacteri
genera
bacillu
ralstonia
aeromona
rhodobact
rhodospirillum
rhodococcu
shown
suitabl
product
pha
nanobead
edit
streamlin
refactor
wild
type
strain
enhanc
protein
immobil
complex
subcellular
architectur
selforgan
nanoand
microcompart
bacteri
cell
hold
great
promis
larg
due
possibl
biofunction
disturb
highli
coordin
system
might
easili
imbal
physiolog
bacteri
cell
pha
granul
take
control
carbon
energi
storag
thu
repres
import
element
bacteri
metabol
network
thereaft
energi
flow
surviv
physiolog
standpoint
balanc
distribut
pha
daughter
cell
divis
fundament
import
competit
set
understand
pha
machineri
interplay
compon
shown
crucial
optim
vivo
system
product
protein
function
pha
nanobead
differ
scenario
involv
differ
molecular
event
interact
well
granul
local
propos
micel
bud
scaffold
model
granul
format
contrast
micel
model
pha
granul
assum
randomli
distribut
cytoplasm
bud
scaffold
model
suggest
defin
local
propos
granulecel
membran
interact
phacscaffold
molecul
interplay
respect
recent
propos
scaffold
model
suggest
cooper
work
phac
phasin
granul
format
sinc
phasinsphac
interact
spot
bacteri
strain
eg
pham
phasinlik
protein
interact
phac
r
eutropha
phasin
propos
main
compon
form
network
interconnect
granul
dna
enzym
involv
pha
metabol
network
serv
mediat
element
respons
granul
local
within
cell
balanc
segreg
daughter
cell
cell
divis
gap
interact
depend
activ
function
other
still
discov
instanc
homooligomer
r
eutropha
reu
phar
reu
p
putida
heterooligomer
phac
bmeg
phar
bmeg
known
essenti
accomplish
function
meanwhil
interact
certain
phasin
pha
player
identifi
exact
function
unravel
name
p
putida
phaf
propos
form
homoand
heterotetram
interact
phai
short
leucin
zipper
anoth
suggest
role
phasin
control
access
pha
depolymeras
inde
weak
interact
report
r
eutropha
interact
taught
contribut
format
netlik
structur
found
vicin
pha
granul
provid
window
system
function
phaf
shown
role
central
player
machineri
control
pha
granul
segreg
local
cell
sinc
show
uniqu
abil
bind
least
two
ligand
pha
granul
nucleoid
peculiar
structur
organ
phaf
two
domain
perform
divers
function
ie
ctermin
histonlik
domain
ntermin
phasinlik
domain
suppli
explan
biolog
role
moreov
whether
p
putida
cytoskelet
gap
protein
facilit
organ
granul
needl
array
like
structur
figur
direct
indirect
interact
phaf
still
open
question
current
precis
mechan
intermediari
phaf
posit
pha
granul
still
unknown
similarli
pham
r
eutropha
bind
dna
pha
therefor
refin
system
need
unravel
puzzl
function
divers
even
multifunct
set
gap
combin
gener
optim
yield
vivo
immobil
protein
onto
granul
surfac
engend
coher
cell
phenotyp
step
toward
use
pha
granul
nanocarri
decor
function
phasin
inform
phasin
physiolog
function
provid
import
insight
critic
factor
need
target
improv
exist
model
instanc
phasin
bind
prevent
unspecif
attach
protein
unrel
pha
metabol
granul
surfac
also
limit
space
recombin
protein
anchor
therefor
absenc
wildtyp
phasin
favor
bind
recombin
tag
protein
molecul
anchor
granul
surfac
could
explain
limit
surfac
recombin
protein
anchor
wildtyp
pha
granul
need
compet
natur
phasin
respect
key
phasin
factor
identifi
optim
pha
product
p
putida
address
minimum
amount
complet
phasin
protein
necessari
achiev
adequ
pha
product
higher
yield
immobil
recombin
protein
appli
strategi
maximum
biof
ntermin
phaf
fusion
protein
concentr
vivo
immobil
onto
pha
bead
recombin
proteinpha
without
compromis
phasin
intrins
function
also
demonstr
swappabl
natur
phai
phasin
biof
pha
bind
modul
term
physiolog
function
illustr
util
phafphai
structur
redund
autonom
modular
cooper
work
unit
altogeth
exampl
show
escal
drive
identifi
connect
within
complex
system
gap
network
fuel
need
develop
new
strategi
lead
improv
protein
immobil
onto
pha
bead
metabol
biotechnolog
capac
p
putida
well
global
understand
capabl
strain
facilit
metabol
model
enabl
integr
experiment
along
genom
highthroughput
data
endotoxin
free
pha
nanobead
product
bacteri
lipopolysaccharid
lp
endotoxin
also
design
pathogen
associ
molecular
pattern
pamp
recogn
innat
immun
system
potent
identifi
microbi
mediat
implic
pathogenesi
sepsi
septic
shock
lp
promin
alarm
molecul
sens
host
earli
warn
system
innat
immun
presag
threat
invas
gramneg
bacteri
pathogen
thu
presenc
lipopolysaccharid
lp
endotoxin
pha
nanobead
produc
gramneg
bacteria
make
vivo
natur
produc
particl
unsuit
biomed
applic
problem
occur
copurif
pyrogen
outer
lp
togeth
pha
granul
avoid
vitro
approach
hand
offer
possibl
endotoxin
remov
pha
polym
concentr
endotoxin
pha
greatli
influenc
purif
strategi
might
vari
eug
less
eug
methodolog
endotoxin
elimin
depend
type
pha
eg
sclpha
mclpha
presenc
function
group
etc
result
differ
rate
polym
recoveri
howev
vitro
strategi
remain
hamper
necess
extens
tediou
purif
methodolog
achiev
level
complianc
endotoxin
requir
biomed
applic
accord
us
food
drug
administr
fda
gener
product
directli
indirectli
contact
cardiovascular
system
lymphat
system
limit
euml
eu
devic
devic
contact
cerebrospin
fluid
limit
euml
eudevic
mention
factor
togeth
bacteria
growth
condit
significantli
influenc
total
cost
product
endotoxinfre
polym
get
around
limit
altern
sourc
function
pha
granul
free
lp
contamin
gramposit
bacteria
offer
platform
product
lp
free
tailor
bead
due
differ
structur
cell
envelop
compar
gramneg
bacteria
even
pamp
lipoteicho
acid
lta
peptidoglycan
pg
found
gramposit
bacteri
pathogen
appreci
activ
mani
similar
host
defens
network
induc
lp
subsequ
presenc
pha
isol
gramposit
bacteria
might
immunogen
activ
similar
lp
among
pamp
lta
predomin
bacillu
wherea
actinomycet
bacteria
typic
synthes
lipoglycan
importantli
certain
gramposit
pha
produc
strain
eg
bacillu
circulan
bacillu
polymyxa
lack
lta
lipoglycan
clostridium
staphylococcu
citreu
report
lack
lta
may
consid
recombin
pha
product
henc
emerg
area
investig
mechan
trigger
pamp
gramposit
pha
produc
bacteria
regard
mammalian
immun
system
remark
gramposit
genera
corynebacterium
nocardia
rhodococcu
wildtyp
bacteria
natur
synthes
commerci
import
copolym
poli
p
simpl
carbon
sourc
glucos
genu
bacillu
common
mani
phaaccumul
gramposit
bacteria
accumul
copolym
grown
differ
substrat
instanc
copolym
p
accumul
cultur
fed
oddchainlength
nalkano
acid
propion
acid
valer
acid
heptano
acid
generallyregardedassaf
gra
bacterium
lactococcu
lacti
genet
engin
produc
pha
bead
unfortun
recombin
strain
show
feasibl
commercialscal
product
sinc
bead
smaller
size
contribut
less
pha
per
cdw
pha
produc
bacteria
therefor
platform
design
ad
valu
medic
product
synthesi
eg
vaccin
develop
instead
larg
scale
product
improv
yield
would
like
requir
reengin
metabol
flux
push
carbon
util
away
lactat
product
toward
pha
biosynthesi
pathway
interestingli
platform
base
pha
function
granul
use
develop
phapbas
system
endotoxin
remov
protein
solut
endotoxin
receptor
protein
fuse
r
eutropha
phasin
vitro
attach
phb
bead
use
remov
lp
solut
function
pha
nanobead
vivo
perform
cytotox
biocompat
numer
vivo
studi
clearli
demonstr
endotoxin
bacteri
protein
free
pha
provok
mild
host
reaction
differ
anim
model
surpris
consid
fact
r
acid
normal
blood
constitu
found
cell
envelop
eukaryot
vitro
base
approach
focus
enhanc
growth
differ
eukaryot
cell
line
use
arginylglycylaspart
acid
rgd
tailor
pha
form
scaffold
show
excel
vitro
perform
support
promot
neural
stem
cell
human
bone
marrow
mesenchym
stem
cell
fibroblast
adhes
growth
phaprgd
fusion
immobil
allow
evad
tediou
crosslink
process
chemic
immobil
easili
damag
biolog
activ
attach
protein
new
approach
base
nanoparticul
carrier
target
capabl
imag
drug
deliveri
cancer
cell
slowli
replac
longstand
concept
aim
posterior
synthesi
load
pha
particl
surfac
modif
perform
via
hydrophob
interact
particl
surfac
grow
pha
chain
phac
enzym
fusion
rgd
stabil
coreshel
structur
howev
littl
attent
place
endotoxin
remov
scaffold
perform
vivo
altern
pha
micel
synthesi
perform
vitro
mix
phacrgd
therefor
avoid
incorpor
endotoxin
bacteri
polyest
inclus
also
engin
display
fusion
protein
phac
compon
involv
immun
respons
infecti
agent
use
vaccin
deliveri
system
remark
particlebas
carrier
close
mimic
physiochem
characterist
natur
pathogen
enhanc
particledisplay
protein
deliveri
immun
system
howev
vivo
studi
address
essenti
issu
immunogen
solubl
pha
granul
bound
gap
consid
main
object
use
biomateri
nanocarri
gener
appropri
benefici
cellular
tissu
respons
without
elicit
undesir
local
system
effect
recipi
therapi
immun
respons
repair
function
bodi
except
complex
biocompat
materi
describ
relat
singl
cell
type
tissu
nevertheless
essenti
consid
vitro
vivo
cellular
behavior
comprehens
biocompat
evalu
biopolym
sever
studi
report
toxic
pyrogen
effect
wild
type
function
non
endotoxin
free
pha
bead
mice
suggest
due
profound
differ
mice
human
immun
system
anoth
anim
model
consid
type
studi
given
breadth
function
differ
discrep
sure
limit
use
mous
model
mention
studi
taken
account
choos
preclin
anim
model
result
studi
compar
immun
respons
phabead
vaccin
applic
produc
l
lacti
e
coil
support
hypothesi
sinc
higher
inflamm
spot
e
coli
produc
particl
howev
might
due
pamp
present
gramposit
gramneg
bacteria
induc
similar
immun
reaction
addit
overal
impact
function
pha
nanobead
eukaryot
organ
includ
level
keton
bodi
possibl
secondari
effect
unknown
vivo
track
pha
nanocarri
might
give
insight
environmentallytrigg
structur
chang
nanoparticl
provid
addit
inform
local
pathway
differ
context
complex
pha
cpha
discov
repres
differ
type
pha
structur
unlik
bacteri
pha
play
major
role
carbon
energi
store
cpha
found
mammalian
cell
assum
involv
regul
variou
cell
function
modif
target
molecul
complex
cpha
ca
inorgan
polyphosph
involv
format
ionconduct
channel
mitochondri
membran
furthermor
cpha
interact
membran
protein
hydrophob
perhap
coval
interact
suggest
case
protein
channel
interact
might
play
import
role
regul
channel
function
select
previou
studi
indic
cpha
found
variou
subcellular
compart
eukaryot
organ
well
associ
specif
protein
although
structur
still
profoundli
explor
earli
stage
investig
definit
offer
great
possibl
function
exploit
addit
might
give
critic
piec
inform
pha
metabol
uptak
pathway
insid
eukaryot
cell
essenti
deal
function
pha
nanobead
design
biomed
applic
besid
natur
polyest
pha
sever
synthet
polyest
attract
consider
attent
materi
biomed
purpos
due
attract
properti
eg
biocompat
biodegrad
current
major
synthet
polyest
system
use
medicin
base
poli
lactic
acid
pla
poli
glycol
acid
pga
copolym
poli
lacticcoglycol
acid
plga
mainli
due
well
describ
formul
method
product
well
low
toxic
immunogen
even
though
polyest
extens
use
resorb
sutur
bone
implant
screw
other
small
number
commerci
avail
product
design
nanoparticl
base
drug
deliveri
nevertheless
synthet
polyest
plga
profoundli
test
applic
review
synthet
polyest
consid
promis
candid
develop
nanoparticl
deliveri
system
releas
target
uptak
retain
activ
local
drug
right
time
place
dose
although
natur
synthet
polyest
share
mani
common
properti
eg
biocompat
biodegrad
due
specif
characterist
one
might
suitabl
depend
applic
main
characterist
synthet
natur
polyest
signific
nanoparticl
product
drug
deliveri
system
outlin
tabl
degrad
synthet
natur
polyest
result
biolog
compat
metaboliz
moieti
howev
degrad
rate
pattern
differ
consider
therebi
synthet
polyest
suitabl
sustain
releas
due
slow
degrad
rate
importantli
case
natur
polyest
drug
releas
kinet
easili
control
via
convent
engin
pha
matrix
paramet
reach
desir
degrad
rate
instanc
sclpha
crystallin
hydrophob
mani
pore
form
surfac
drug
releas
quickli
without
polym
degrad
mclpha
copolym
hand
low
melt
point
low
crystallin
therefor
suitabl
drug
deliveri
plga
found
mani
applic
biomed
field
treatment
cancer
inflamm
diseas
cerebr
diseas
cardiovascular
diseas
well
regen
medicin
infect
treatment
vaccin
mani
other
also
use
diagnost
purpos
magnet
reson
cancertarget
imag
ultrasound
contrast
agent
similarli
good
perform
pha
varieti
biomed
applic
proven
tabl
nevertheless
main
advantag
synthet
plga
natur
pha
fda
approv
drug
deliveri
platform
lower
product
cost
current
fda
approv
pha
poli
p
sutur
applic
might
open
possibl
pha
test
enter
investig
fda
approv
would
significantli
influenc
develop
pha
base
drug
deliveri
system
enhanc
applic
present
due
larg
avail
market
rel
low
price
pla
show
one
highest
potenti
among
polyest
particularli
packag
medic
applic
instanc
cargil
develop
process
use
corn
feedstock
produc
differ
pla
grade
naturework
compani
actual
product
estim
tonsyear
present
highest
worldwid
product
biodegrad
polyest
price
lower
although
cost
product
pha
still
quit
high
current
advanc
ferment
extract
purif
technolog
well
develop
superior
bacteri
strain
like
lower
price
pha
close
biodegrad
polym
polylactid
aliphat
polyest
engin
biomateri
nanobead
attract
much
attent
research
commun
ongo
effort
push
boundari
reflect
design
wide
rang
nanostructur
bacteri
materi
innov
medicin
apart
pha
biolog
produc
nanoparticl
highli
divers
omnipres
prokaryot
magnetosom
storag
paricl
etc
also
eukaryot
eg
exosom
lipoprotein
etc
system
give
ground
develop
bionanothechnolog
smart
pha
nanoparticl
describ
review
provid
ground
bacteri
polym
tradit
consid
industri
convent
clinic
applic
progress
enter
innov
biomed
field
promis
highli
flexibl
materi
fact
pha
produc
inexpens
wast
carbon
sourc
enhanc
commerci
interest
polym
hand
interest
function
pha
nanobead
technolog
hamper
exist
legisl
term
endotoxin
concentr
allow
biomed
applic
importantli
technic
hurdl
success
surmount
follow
vitro
approach
use
certain
gramposit
strain
vivo
function
bead
assembl
nevertheless
uptod
pha
produc
largescal
exclus
use
gramneg
bacteria
simplic
cost
control
goal
adapt
approach
system
maxim
cover
pha
granul
surfac
recombin
protein
achiev
differ
modul
swap
strategi
fine
tune
proven
effect
reach
goal
meet
challeng
new
tendenc
suggest
multifunction
concept
behind
multifunct
bead
would
allow
design
varieti
biomed
system
uniqu
advantag
adapt
subsequ
respond
current
trend
biomedicin
pha
nanoparticl
allow
multifunct
tune
due
possibl
use
varieti
gap
well
nand
ctermin
domain
immobil
divers
protein
simultan
nevertheless
mani
nanotoxicolog
test
safeti
perform
overtak
current
stage
synthet
polyest
asid
fda
approv
biomed
applic
product
cost
reduc
tabl
comparison
synthet
natur
polyest
product
process
properti
applic
bacteri
polyest
pha
ref
bioproduct
la
chemic
synthesi
pla
plga
complet
biosynthes
possibl
vivo
product
function
vivo
function
onestep
product
activ
agent
carrier
need
produc
purifi
conjug
activ
agent
use
harsh
chemic
product
product
renew
sourc
difficulti
scaleup
similar
bioprocess
pha
product
certain
difficulti
scaleup
product
cost
compar
convent
plastic
like
pet
high
cost
product
least
twice
pla
high
risk
due
flammabl
toxic
solvent
low
risk
level
product
complet
within
day
product
durat
week
endotoxin
contamin
less
probabl
due
synthet
origin
endotoxin
effici
remov
use
gram
strain
allow
endotoxin
free
product
properti
lower
number
copolym
produc
dand
llactic
acid
la
monomer
build
block
polym
design
approv
fda
european
medicin
agenc
drug
deliveri
system
approv
fda
drug
deliveri
system
low
drug
load
limit
regard
drug
load
protect
drug
degrad
protect
drug
degrad
biodegrad
biocompat
low
cytotox
biodegrad
biocompat
low
cytotox
materi
properti
poor
could
adjust
regul
dand
lla
ratio
good
thermomechan
properti
brittl
flexibl
elast
fulli
control
easi
process
degrad
rate
control
degrad
rate
control
drug
deliveri
kinet
control
drug
deliveri
kinet
control
easi
particl
size
control
size
vitro
produc
particl
might
control
vivo
product
limit
control
particl
size
applic
wind
varieti
biomed
applic
applic
rang
diseas
lower
ph
site
implant
might
lead
steril
sepsi
detect
side
effect
pha
degrad
best
chanc
clinic
applic
due
fda
approv
packag
print
coat
yet
limit
g
almost
area
convent
plastic
industri
limit
current
higher
cost
avail
big
challeng
pha
industri
overcom
lead
pha
nanobead
success
commerci
reduct
product
cost
ii
construct
function
pha
product
strain
precis
control
structur
pha
molecul
increas
consist
structur
properti
reach
level
competitor
synthet
polym
iii
reach
simplic
synthet
polym
process
iv
use
altern
renew
sourc
product
avoid
use
expens
glucos
v
develop
high
valu
ad
applic
